An Old Medical Text Helped Researchers Change a Malaria Experiment

1. Project 523

In 1967, the People's Liberation Army established a secret research program code-named Project 523. The initiative aimed to find an adequate treatment for drug-resistant malaria strains. North Vietnamese leaders had requested assistance for their malaria-ridden army during wartime. Researchers began screening thousands of potential traditional Chinese medicines.

Scientists examined historical medical texts for promising herbal leads.

2. Historical Clues

Tu Youyou led a research team tasked with investigating traditional herbal remedies for active compounds. She consulted historical texts, including a manual written in 340 CE by Ge Hong. This text recommended steeping sweet wormwood in cold water rather than boiling it. The specific preparation instruction provided a crucial clue for preserving the active ingredient.

Boiling the herb apparently destroyed the therapeutic properties entirely.

3. Successful Extraction

In 1972, Tu Youyou successfully isolated an active antimalarial extract from the leaves of Artemisia annua. The extraction process used a low-temperature solvent to avoid degrading the sensitive chemical compound. The purified substance demonstrated high efficacy against malaria parasites during initial laboratory tests. Researchers named the compound qinghaosu.

Detailed findings were published in scientific journals years later.

4. Chemical Structure

Laboratory analysis revealed that artemisinin was a sesquiterpene lactone containing an unusual peroxide bridge. This endoperoxide ring proved essential for its rapid antimalarial properties. When the drug encountered iron inside red blood cells, the ring cleaved to produce free radicals. These radicals damaged parasite proteins and caused their death.

The unique chemical structure distinguished it from existing antimalarial drugs.

5. Semisynthetic Derivatives

Because natural artemisinin had low solubility and poor bioavailability, chemists developed semisynthetic derivatives. Compounds such as artesunate, artemether, and arteether were subsequently synthesized to improve potency. These derivatives allowed for intravenous and intramuscular administration in severe malaria cases. Clinical guidelines established combination therapies to prevent drug resistance.

Monotherapy use was discouraged to protect treatment longevity.

6. Synthetic Biology

A collaborative partnership began in 2004 to produce artemisinin through industrial fermentation processes. Researchers at the University of California, Berkeley, engineered yeast to produce artemisinic acid. Biotechnology firms refined the process for large-scale industrial manufacturing. A production facility in Italy opened to supply commercial quantities.

The initiative aimed to stabilize global supplies and reduce costs.

7. Global Deployment

The World Health Organization recommended artemisinin-based combination therapies as frontline malaria treatment worldwide. Pharmaceutical companies partnered to provide the medications on a nonprofit basis. Large-scale distribution campaigns achieved dramatic reductions in malaria cases in endemic regions. Millions of treatment courses were shipped to affected countries.

Combination treatments became the standard of care globally.

8. Emerging Resistance

Clinical evidence of artemisinin resistance emerged in Southeast Asia during the late 2000s. Researchers identified specific genetic mutations associated with reduced parasite susceptibility to the drug. The World Health Organization warned against unmonitored single-drug usage to preserve efficacy. Surveillance programs tracked resistance patterns across multiple countries.

Protecting combination therapies remained a critical public health priority.

9. Lasker Award

Tu Youyou received the Lasker-DeBakey Clinical Medical Research Award in 2011 for the work leading to artemisinin. The award account described the investigation and its contribution to malaria treatment. It preceded the Nobel Prize announcement in 2015, when Tu’s discovery was recognized alongside separate work by William Campbell and Satoshi Omura on another treatment.

The Lasker award preceded the Nobel Prize announced in 2015.

10. Nobel Prize

Tu Youyou received half of the 2015 Nobel Prize in Physiology or Medicine for the discovery of artemisinin; the other half went to work on a different treatment. The award followed the extraction research and development of the antimalarial compound. The historical result concerned identifying and testing an active substance, rather than treating the old text itself as proof that every traditional preparation worked.

The extraction research led to an identified active compound.

Sources

• Original narrative adaptation — CC BY-SA 4.0
• Wikipedia contributors — Artemisinin (CC BY-SA 4.0)